IL143356A0 - An oral formulation for gastrointestinal drug delivery - Google Patents
An oral formulation for gastrointestinal drug deliveryInfo
- Publication number
- IL143356A0 IL143356A0 IL14335699A IL14335699A IL143356A0 IL 143356 A0 IL143356 A0 IL 143356A0 IL 14335699 A IL14335699 A IL 14335699A IL 14335699 A IL14335699 A IL 14335699A IL 143356 A0 IL143356 A0 IL 143356A0
- Authority
- IL
- Israel
- Prior art keywords
- layer
- drug
- drug delivery
- oral formulation
- protecting
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP35396698 | 1998-11-27 | ||
JP26643399 | 1999-09-21 | ||
PCT/JP1999/006602 WO2000032172A1 (en) | 1998-11-27 | 1999-11-26 | An oral formulation for gastrointestinal drug delivery |
Publications (1)
Publication Number | Publication Date |
---|---|
IL143356A0 true IL143356A0 (en) | 2002-04-21 |
Family
ID=26547440
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14335699A IL143356A0 (en) | 1998-11-27 | 1999-11-26 | An oral formulation for gastrointestinal drug delivery |
Country Status (17)
Country | Link |
---|---|
US (1) | US7097851B1 (es) |
EP (1) | EP1135112B1 (es) |
JP (1) | JP4497725B2 (es) |
KR (1) | KR100762475B1 (es) |
CN (1) | CN1161107C (es) |
AT (1) | ATE279914T1 (es) |
AU (1) | AU766293B2 (es) |
BR (1) | BR9916871A (es) |
CA (1) | CA2352389C (es) |
DE (1) | DE69921353T2 (es) |
DK (1) | DK1135112T3 (es) |
ES (1) | ES2233106T3 (es) |
HK (1) | HK1043545A1 (es) |
ID (1) | ID29085A (es) |
IL (1) | IL143356A0 (es) |
MX (1) | MXPA01005346A (es) |
WO (1) | WO2000032172A1 (es) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1284137B1 (en) * | 2000-05-26 | 2010-12-01 | TAKADA, Kanji | Nonoral preparation having three-layer structure |
KR20040018333A (ko) * | 2001-02-16 | 2004-03-03 | 시미즈 세이야꾸 가부시키가이샤 | 소장 전달용 점액다당류 함유 경구 제형, 및 순환 장애치료에서의 이들의 용도 |
DE10120092B4 (de) * | 2001-04-25 | 2008-03-20 | Lts Lohmann Therapie-Systeme Ag | Magensaftresistente Vorrichtung zur Freisetzung von mukoadhäsiven Wirkstoffträgern und Verfahren zur Herstellung der magensaftresistenten Vorrichtung |
AU2002319653A1 (en) * | 2001-07-20 | 2003-03-03 | Samir Mitragotri | Method for oral drug delivery |
US6585997B2 (en) * | 2001-08-16 | 2003-07-01 | Access Pharmaceuticals, Inc. | Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
WO2003026699A1 (fr) * | 2001-09-26 | 2003-04-03 | Tanabe Seiyaku Co., Ltd. | Compositions medicinales favorisant l'absorption de medicaments |
US20060034929A1 (en) * | 2001-12-27 | 2006-02-16 | Brubaker Michael J | Sustained release drug delivery devices with prefabricated permeable plugs |
US7200424B2 (en) | 2002-07-15 | 2007-04-03 | Bellsouth Intelectual Property Corporation | Systems and methods for restricting the use and movement of telephony devices |
US8275371B2 (en) * | 2002-07-15 | 2012-09-25 | At&T Intellectual Property I, L.P. | Apparatus and method for providing communications and connection-oriented services to devices |
US8543098B2 (en) | 2002-07-15 | 2013-09-24 | At&T Intellectual Property I, L.P. | Apparatus and method for securely providing communications between devices and networks |
US8554187B2 (en) | 2002-07-15 | 2013-10-08 | At&T Intellectual Property I, L.P. | Apparatus and method for routing communications between networks and devices |
US8526466B2 (en) | 2002-07-15 | 2013-09-03 | At&T Intellectual Property I, L.P. | Apparatus and method for prioritizing communications between devices |
TWI355276B (en) | 2003-01-14 | 2012-01-01 | Akira Tsuji | Gastrointestinal absorption enhancer mediated by p |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
PT1682537E (pt) | 2003-11-05 | 2012-06-20 | Sarcode Bioscience Inc | Moduladores de adesão celular |
WO2006026556A2 (en) * | 2004-08-27 | 2006-03-09 | Spherics, Inc. | Bioadhesive rate-controlled oral dosage formulations |
KR100638041B1 (ko) * | 2003-12-24 | 2006-10-23 | 주식회사 삼양사 | 수용성 약물의 경구투여용 나노입자 조성물 및 그의제조방법 |
JP4606748B2 (ja) * | 2004-02-06 | 2011-01-05 | 京セラケミカル株式会社 | 固形製剤の製造方法 |
AR048033A1 (es) * | 2004-03-12 | 2006-03-22 | Smithkline Beecham Plc | Composicion farmaceutica para moldear componentes que comprende copolimero de poli(met)acrilato, cubierta, conector o espaciador de capsula moldeado por inyeccion que tiene la composicion farmaceutica y forma de dosificacion farmaceutica de multicomponentes a partir de dicha composicion |
AT502098B8 (de) * | 2004-07-07 | 2007-06-15 | Albert Dr Missbichler | Diaminooxidase-hältige zusammensetzung |
JP4787503B2 (ja) * | 2005-01-12 | 2011-10-05 | 京セラケミカル株式会社 | 固形製剤の製造方法 |
JP4787507B2 (ja) * | 2005-01-24 | 2011-10-05 | 京セラケミカル株式会社 | 固形製剤及びその製造方法 |
JP2008155067A (ja) * | 2005-04-14 | 2008-07-10 | Toray Eng Co Ltd | マイクロカプセル製造方法、マイクロカプセル製造装置、およびマイクロカプセルシート |
DK1881823T3 (en) | 2005-05-17 | 2015-03-02 | Sarcode Bioscience Inc | COMPOSITION AND PROCEDURES FOR TREATMENT OF EYE DISORDERS |
WO2007083698A1 (ja) * | 2006-01-19 | 2007-07-26 | Toray Engineering Co., Ltd, | 積層型マイクロカプセルシートおよびその製造方法 |
JP2007246412A (ja) * | 2006-03-14 | 2007-09-27 | Serubakku:Kk | 消化管用経口製剤とその製造方法および消化管用経口カプセル剤 |
US20100136123A1 (en) * | 2006-10-12 | 2010-06-03 | Toray Engineering Co., Ltd. | Microcapsule Sheet |
AU2008238634B2 (en) * | 2007-03-30 | 2013-01-17 | Lintec Corporation | Film-like orally administered medication and manufacturing method therefor |
US20100303901A1 (en) * | 2007-04-26 | 2010-12-02 | Eyal Shimoni | Oral delivery of proteins and peptides |
US20090105561A1 (en) * | 2007-10-17 | 2009-04-23 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Medical or veterinary digestive tract utilization systems and methods |
US8303573B2 (en) | 2007-10-17 | 2012-11-06 | The Invention Science Fund I, Llc | Medical or veterinary digestive tract utilization systems and methods |
US8789536B2 (en) | 2007-10-17 | 2014-07-29 | The Invention Science Fund I, Llc | Medical or veterinary digestive tract utilization systems and methods |
US8707964B2 (en) * | 2007-10-31 | 2014-04-29 | The Invention Science Fund I, Llc | Medical or veterinary digestive tract utilization systems and methods |
ES2830024T3 (es) | 2007-10-19 | 2021-06-02 | Novartis Ag | Composiciones y métodos para el tratamiento del edema macular |
US8808276B2 (en) * | 2007-10-23 | 2014-08-19 | The Invention Science Fund I, Llc | Adaptive dispensation in a digestive tract |
US8808271B2 (en) * | 2007-10-31 | 2014-08-19 | The Invention Science Fund I, Llc | Medical or veterinary digestive tract utilization systems and methods |
US8109920B2 (en) * | 2007-10-31 | 2012-02-07 | The Invention Science Fund I, Llc | Medical or veterinary digestive tract utilization systems and methods |
US8333754B2 (en) * | 2007-10-31 | 2012-12-18 | The Invention Science Fund I, Llc | Medical or veterinary digestive tract utilization systems and methods |
US20090163894A1 (en) * | 2007-10-31 | 2009-06-25 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Medical or veterinary digestive tract utilization systems and methods |
US20090137866A1 (en) * | 2007-11-28 | 2009-05-28 | Searete Llc, A Limited Liability Corporation Of The State Delaware | Medical or veterinary digestive tract utilization systems and methods |
US8080562B2 (en) * | 2008-04-15 | 2011-12-20 | Sarcode Bioscience Inc. | Crystalline pharmaceutical and methods of preparation and use thereof |
MX2020005326A (es) | 2008-08-15 | 2022-03-03 | Ironwood Pharmaceuticals Inc | Formulaciones que contienen linaclotida para administracion oral. |
MX2012001660A (es) | 2009-08-06 | 2012-03-26 | Ironwood Pharmaceuticals Inc | Formulaciones que contienen linaclotida para adminstracion oral. |
WO2011050175A1 (en) | 2009-10-21 | 2011-04-28 | Sarcode Corporation | Crystalline pharmaceutical and methods of preparation and use thereof |
US20110142889A1 (en) * | 2009-12-16 | 2011-06-16 | Nod Pharmaceuticals, Inc. | Compositions and methods for oral drug delivery |
JP2013514976A (ja) | 2009-12-16 | 2013-05-02 | ノッド ファーマシューティカルズ, インコーポレイテッド | 経口薬物送達のための組成物および方法 |
WO2011103311A2 (en) | 2010-02-17 | 2011-08-25 | Ironwood Pharmaceuticals, Inc | Treatments for gastrointestinal disorders |
US20140005128A1 (en) | 2010-08-11 | 2014-01-02 | Forest Laboratories Holdings Limited | Treatments of gastrointestinal disorders |
US9782354B2 (en) * | 2010-08-25 | 2017-10-10 | II Grant Rufus Sparling | Enteric active substance delivery |
US9808418B2 (en) | 2010-11-26 | 2017-11-07 | University Of The Witwatersrand, Johannesburg | Pharmaceutical dosage form |
EP2776055B1 (en) | 2011-08-17 | 2016-12-14 | Ironwood Pharmaceuticals, Inc. | Treatments for gastrointestinal disorders |
WO2014018075A1 (en) | 2012-07-23 | 2014-01-30 | Crayola, Llc | Dissolvable films and methods of using the same |
CN110922393A (zh) | 2012-07-25 | 2020-03-27 | 诺华股份有限公司 | Lfa-1抑制剂及其多晶型物 |
CN110809464A (zh) * | 2017-06-27 | 2020-02-18 | 株式会社培旺精廉宅 | 粘膜附着性口服制剂 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4451260A (en) * | 1982-03-26 | 1984-05-29 | Minnesota Mining And Manufacturing Company | Sustained release oral medicinal delivery device |
US4767627A (en) * | 1985-05-29 | 1988-08-30 | Merck & Co., Inc. | Drug delivery device which can be retained in the stomach for a controlled period of time |
JPS61280423A (ja) * | 1985-06-05 | 1986-12-11 | Kiyuukiyuu Yakuhin Kogyo Kk | 口腔内粘膜貼付剤 |
JPH07121859B2 (ja) * | 1986-03-18 | 1995-12-25 | 第一製薬株式会社 | 徐放性カプセル剤 |
US5196202A (en) * | 1986-09-01 | 1993-03-23 | Teikoku Seiyaku Kabushiki Kaisha | Sustained release dosage form |
US5236713A (en) * | 1987-10-21 | 1993-08-17 | Teikoku Seiyaku Kabushiki Kaisha | Preparation for intermittently releasing active agent applicable to oral cavity |
US5350741A (en) | 1988-07-30 | 1994-09-27 | Kanji Takada | Enteric formulations of physiologically active peptides and proteins |
US5496559A (en) * | 1991-04-08 | 1996-03-05 | Sumitomo Pharmaceuticals Company, Limited | Porous solid formulations containing proteinaceous physiologically active substances |
US5686105A (en) * | 1993-10-19 | 1997-11-11 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
AU7568394A (en) * | 1993-08-19 | 1995-03-14 | Cygnus Therapeutic Systems | Water-soluble pressure-sensitive mucoadhesive and devices provided therewith for emplacement in a mucosa-lined body cavity |
US5637319A (en) | 1995-03-01 | 1997-06-10 | Takada; Kanji | Controlled-release preparations |
AUPN605795A0 (en) * | 1995-10-19 | 1995-11-09 | F.H. Faulding & Co. Limited | Analgesic pharmaceutical composition |
US6231888B1 (en) * | 1996-01-18 | 2001-05-15 | Perio Products Ltd. | Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps |
DE19646392A1 (de) * | 1996-11-11 | 1998-05-14 | Lohmann Therapie Syst Lts | Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht |
US6086869A (en) * | 1996-11-22 | 2000-07-11 | Toray Industries, Inc. | Use of interferon-β or γ to treat retinal edema |
WO1998024412A2 (en) * | 1996-12-05 | 1998-06-11 | The Board Of Trustees Of The University Of Illinois | Compounds useful against diseases of the colon and methods for orally administering same |
AU2546399A (en) * | 1998-02-10 | 1999-08-30 | Yoshitomi Pharmaceutical Industries, Ltd. | Preparations with controlled release |
-
1999
- 1999-11-26 CA CA002352389A patent/CA2352389C/en not_active Expired - Fee Related
- 1999-11-26 JP JP2000584868A patent/JP4497725B2/ja not_active Expired - Fee Related
- 1999-11-26 DK DK99972918T patent/DK1135112T3/da active
- 1999-11-26 WO PCT/JP1999/006602 patent/WO2000032172A1/en active IP Right Grant
- 1999-11-26 BR BR9916871-5A patent/BR9916871A/pt not_active Application Discontinuation
- 1999-11-26 ES ES99972918T patent/ES2233106T3/es not_active Expired - Lifetime
- 1999-11-26 EP EP99972918A patent/EP1135112B1/en not_active Expired - Lifetime
- 1999-11-26 IL IL14335699A patent/IL143356A0/xx unknown
- 1999-11-26 KR KR1020017006640A patent/KR100762475B1/ko not_active IP Right Cessation
- 1999-11-26 ID IDW00200101320A patent/ID29085A/id unknown
- 1999-11-26 AT AT99972918T patent/ATE279914T1/de not_active IP Right Cessation
- 1999-11-26 MX MXPA01005346A patent/MXPA01005346A/es not_active Application Discontinuation
- 1999-11-26 CN CNB998158186A patent/CN1161107C/zh not_active Expired - Fee Related
- 1999-11-26 DE DE69921353T patent/DE69921353T2/de not_active Expired - Lifetime
- 1999-11-26 AU AU14101/00A patent/AU766293B2/en not_active Ceased
- 1999-11-26 US US09/831,901 patent/US7097851B1/en not_active Expired - Fee Related
-
2002
- 2002-07-17 HK HK02105302.0A patent/HK1043545A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
DK1135112T3 (da) | 2005-02-14 |
MXPA01005346A (es) | 2003-03-27 |
DE69921353D1 (de) | 2004-11-25 |
WO2000032172A1 (en) | 2000-06-08 |
KR100762475B1 (ko) | 2007-10-04 |
CA2352389C (en) | 2009-01-20 |
US7097851B1 (en) | 2006-08-29 |
EP1135112B1 (en) | 2004-10-20 |
ES2233106T3 (es) | 2005-06-01 |
CN1333680A (zh) | 2002-01-30 |
ATE279914T1 (de) | 2004-11-15 |
DE69921353T2 (de) | 2005-11-10 |
HK1043545A1 (zh) | 2002-09-20 |
JP2002531394A (ja) | 2002-09-24 |
AU766293B2 (en) | 2003-10-16 |
ID29085A (id) | 2001-07-26 |
KR20010086057A (ko) | 2001-09-07 |
AU1410100A (en) | 2000-06-19 |
CN1161107C (zh) | 2004-08-11 |
CA2352389A1 (en) | 2000-06-08 |
JP4497725B2 (ja) | 2010-07-07 |
EP1135112A1 (en) | 2001-09-26 |
BR9916871A (pt) | 2001-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL143356A0 (en) | An oral formulation for gastrointestinal drug delivery | |
AU3287699A (en) | Ultrasound-mediated drug delivery | |
AU2879100A (en) | Formulation and system for intra-oral delivery of pharmaceutical agents | |
AU6776700A (en) | Implantable drug delivery catheter system with capillary interface | |
AU1967601A (en) | Drug delivery system for implantable cardiac device | |
CA2329128A1 (en) | Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces | |
AU2002363998A1 (en) | Bioadhesive drug delivery system with enhanced gastric retention | |
AU6141199A (en) | Multiplex drug delivery system suitable for oral administration | |
AU7796198A (en) | Novel acoustically active drug delivery systems | |
AU4947100A (en) | Drug delivery device | |
AU7839900A (en) | Reusable medication delivery device | |
NZ513700A (en) | Oral drug delivery system | |
AU4681200A (en) | A pharmaceutical composition of concentrates for microemulsion and self-emulsifying drug delivery system | |
AU4496900A (en) | Improved drug delivery pack | |
AU5060499A (en) | Hydrodynamically balanced oral drug delivery system | |
AU3520900A (en) | Implantable drug delivery system | |
AU2001277171A1 (en) | Catheter for target specific drug delivery | |
AU2293601A (en) | Sender-controlled post delivery handling of digitally delivered documents | |
AU3837999A (en) | Drug delivery device | |
AU1751997A (en) | Targeted delivery of drugs to the lower gastrointestinal tract | |
FR2796287B1 (fr) | Dispositif d'administration de medicament | |
AU6503399A (en) | Drug delivery catheter | |
AU3055099A (en) | A pharmaceutical formulation for nasal administration | |
AU5072000A (en) | Pharmaceutical composition for nasally administering water-soluble active substances | |
AU2003275006A1 (en) | Aerosol drug delivery system employing formulation pre-heating |